oxytocin and Squamous-Cell-Carcinoma-of-Head-and-Neck

oxytocin has been researched along with Squamous-Cell-Carcinoma-of-Head-and-Neck* in 1 studies

Other Studies

1 other study(ies) available for oxytocin and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
Oxytocin inhibits head and neck squamous cell carcinoma cell migration by early growth response-1 upregulation.
    Anti-cancer drugs, 2017, Volume: 28, Issue:6

    The effect of oxytocin (OXT) on cancer invasion is controversial. Few studies have examined the effect of early growth response-1 (EGR1) on the invasion of head and neck squamous cell carcinoma (HNSCC). Here, we evaluated how EGR1 affects HNSCC cell migration through the molecular mechanism of OXT in exerting anti-invasion activity. Matrigel invasion and wound-healing assays were used to measure the in-vitro cell migration. The molecular mechanism of OXT was assessed by knockdown or overexpression of EGR1 in HNSCC cells. Three-dimensional (3-D) spheroids formation, followed by the image analysis for quantification was performed. OXT at 500 nmol/l increased mRNA and protein expression of E-cadherin without cytotoxicity. OXT upregulated mRNA and protein expression of EGR1 in 6 h. p53, phosphatase and tensin, and p21 expression was increased in an EGR1-dependent manner with OXT treatment. In addition, OXT significantly downregulated 3-D spheroids' formation according to spheroids' number and size. Our data showed that OXT downregulated HNSCC cell migration by EGR1 upregulation. OXT inhibited spheroids' formation of HNSCC cells under 3-D culture conditions.

    Topics: Carcinoma, Squamous Cell; Cell Movement; Early Growth Response Protein 1; Epithelial-Mesenchymal Transition; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Head and Neck Neoplasms; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Oxytocin; Spheroids, Cellular; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured; Up-Regulation

2017